BACKGROUND: Although not fully understood, diabetes mellitus is thought to be associated with cardiac fibrosis and stiffness due to alteration of myocardial extracellular matrix. Newer cardiac magnetic resonance techniques may be able to identify extracellular matrix expansion by measuring extracellular volume fraction (ECV). We used cardiac magnetic resonance to evaluate the association of alteration in the extracellular matrix with diabetic status and its implications on incident heart failure events and all-cause mortality. METHODS: We studied 442 patients who underwent comprehensive contrast cardiac magnetic resonance to assess cardiac morphology and function, left ventricular replacement fibrosis, and pre-post contrast T1 mapping to quantify ECV. The cohort did not have coexisting pathologies associated with ECV alteration. We categorized our final cohort based on diabetic status using criteria from the American Diabetic Association. Subsequent heart failure hospitalization and all-cause death were ascertained. RESULTS: Our patients were predominantly white with a median age of 57 with 48% being men. Compared with nondiabetes mellitus, diabetes mellitus was significantly associated with elevated ECV after adjusting for clinical and imaging covariates: β coefficient 1.33 (95% CI, 0.22-2.44); P=0.02. Over a median follow-up of 24.5 (interquartile range, 14.8-33.4) months, 52 deaths and 24 heart failure events occurred. Patients with diabetes mellitus and elevated ECV had the worst outcomes compared with patients with diabetes mellitus and normal ECV or nondiabetics. Elevated ECV remained an independent predictor of outcomes (hazard ratio, 3.31 [95% CI, 1.93-5.67]; P<0.001) after adjusting for covariates. CONCLUSIONS: Elevated ECV is an independent predictor of mortality among patients with diabetes mellitus and may have an additive effect with diabetes mellitus on outcomes. ECV may represent a novel noninvasive biomarker to evaluate severity of diabetic heart disease.
BACKGROUND: Although not fully understood, diabetes mellitus is thought to be associated with cardiac fibrosis and stiffness due to alteration of myocardial extracellular matrix. Newer cardiac magnetic resonance techniques may be able to identify extracellular matrix expansion by measuring extracellular volume fraction (ECV). We used cardiac magnetic resonance to evaluate the association of alteration in the extracellular matrix with diabetic status and its implications on incident heart failure events and all-cause mortality. METHODS: We studied 442 patients who underwent comprehensive contrast cardiac magnetic resonance to assess cardiac morphology and function, left ventricular replacement fibrosis, and pre-post contrast T1 mapping to quantify ECV. The cohort did not have coexisting pathologies associated with ECV alteration. We categorized our final cohort based on diabetic status using criteria from the American Diabetic Association. Subsequent heart failure hospitalization and all-cause death were ascertained. RESULTS: Our patients were predominantly white with a median age of 57 with 48% being men. Compared with nondiabetes mellitus, diabetes mellitus was significantly associated with elevated ECV after adjusting for clinical and imaging covariates: β coefficient 1.33 (95% CI, 0.22-2.44); P=0.02. Over a median follow-up of 24.5 (interquartile range, 14.8-33.4) months, 52 deaths and 24 heart failure events occurred. Patients with diabetes mellitus and elevated ECV had the worst outcomes compared with patients with diabetes mellitus and normal ECV or nondiabetics. Elevated ECV remained an independent predictor of outcomes (hazard ratio, 3.31 [95% CI, 1.93-5.67]; P<0.001) after adjusting for covariates. CONCLUSIONS: Elevated ECV is an independent predictor of mortality among patients with diabetes mellitus and may have an additive effect with diabetes mellitus on outcomes. ECV may represent a novel noninvasive biomarker to evaluate severity of diabetic heart disease.
Authors: Clyde W Yancy; Mariell Jessup; Biykem Bozkurt; Javed Butler; Donald E Casey; Mark H Drazner; Gregg C Fonarow; Stephen A Geraci; Tamara Horwich; James L Januzzi; Maryl R Johnson; Edward K Kasper; Wayne C Levy; Frederick A Masoudi; Patrick E McBride; John J V McMurray; Judith E Mitchell; Pamela N Peterson; Barbara Riegel; Flora Sam; Lynne W Stevenson; W H Wilson Tang; Emily J Tsai; Bruce L Wilkoff Journal: Circulation Date: 2013-06-05 Impact factor: 29.690
Authors: B Pitt; P A Poole-Wilson; R Segal; F A Martinez; K Dickstein; A J Camm; M A Konstam; G Riegger; G H Klinger; J Neaton; D Sharma; B Thiyagarajan Journal: Lancet Date: 2000-05-06 Impact factor: 79.321
Authors: Nowell M Fine; Shruti Tandon; Han W Kim; Dipan J Shah; Terry Thompson; Maria Drangova; James A White Journal: J Magn Reson Imaging Date: 2013-04-04 Impact factor: 4.813
Authors: Karl-Philipp Rommel; Maximilian von Roeder; Konrad Latuscynski; Christian Oberueck; Stephan Blazek; Karl Fengler; Christian Besler; Marcus Sandri; Christian Lücke; Matthias Gutberlet; Axel Linke; Gerhard Schuler; Philipp Lurz Journal: J Am Coll Cardiol Date: 2016-04-19 Impact factor: 24.094
Authors: Andreas A Kammerlander; Beatrice A Marzluf; Caroline Zotter-Tufaro; Stefan Aschauer; Franz Duca; Alina Bachmann; Klaus Knechtelsdorfer; Matthias Wiesinger; Stefan Pfaffenberger; Andreas Greiser; Irene M Lang; Diana Bonderman; Julia Mascherbauer Journal: JACC Cardiovasc Imaging Date: 2015-12-09
Authors: Yuliya Lytvyn; Petter Bjornstad; Jacob A Udell; Julie A Lovshin; David Z I Cherney Journal: Circulation Date: 2017-10-24 Impact factor: 29.690
Authors: Erik B Schelbert; Kayla M Piehler; Karolina M Zareba; James C Moon; Martin Ugander; Daniel R Messroghli; Uma S Valeti; Chung-Chou H Chang; Sanjeev G Shroff; Javier Diez; Christopher A Miller; Matthias Schmitt; Peter Kellman; Javed Butler; Mihai Gheorghiade; Timothy C Wong Journal: J Am Heart Assoc Date: 2015-12-18 Impact factor: 5.501
Authors: Jagdeep S S Singh; Amir Fathi; Keeran Vickneson; Ify Mordi; Mohapradeep Mohan; J Graeme Houston; Ewan R Pearson; Allan D Struthers; Chim C Lang Journal: Cardiovasc Diabetol Date: 2016-07-15 Impact factor: 9.951
Authors: Wensu Chen; Patrick Doeblin; Sarah Al-Tabatabaee; Karin Klingel; Radu Tanacli; Karl Jakob Weiß; Christian Stehning; Amit R Patel; Burkert Pieske; Jiangang Zou; Sebastian Kelle Journal: Circ Cardiovasc Imaging Date: 2022-04-01 Impact factor: 8.589